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Case Report:
A 33-year-old G6P3023 was found to have a 4.2 cm right adrenal incidentaloma
during an admission for right pyelonephritis. Computed tomography (CT) was performed
to rule out perinephric abscess in the setting of worsening leukocytosis while on
antibiotics (Figure 1). Initial differential diagnosis from endocrinology included
pheochromocytoma and primary aldosteronism. Due to the lack of typical physical exam
stigmata, Cushing syndrome was initially of low concern. Of note, her past medical
history included hypertension treated with amlodipine 10 mg and hydrochlorothiazide
12.5 mg. During admission, extensive endocrine laboratory workup demonstrated an
elevated aldosterone:plasma renin activity (PRA), suppressed dehydroepiandrosterone
(DHEA), normal 24 hour urine metanephrine and catecholamine, and hypokalemia
(Table 1). This initial biochemical workup did not provide any definitive diagnosis;
however, it did convincingly rule out pheochromocytoma due to the normal
catecholamine levels in the serum and urine. Eliminating this pathology was critical due
to the mortality of hypertensive crisis in the perioperative period.
After discharge from the hospital, the patient was lost to endocrine and surgical
follow-up, so no further endocrine diagnostic workup was performed during that time.
Approximately 2 months after discharge, the patient was found to be pregnant and
established care with maternal-fetal medicine, endocrinology and urology. Her
obstetrical course was complicated by worsening hypertension (130/100 at 8 weeks
gestation), requiring the addition of labetalol 100 mg BID. Despite this, she had
worsening hypertension (160/100 and 147/97 at 14 and 17 weeks, respectively), so her
labetalol dose was increased to 200 mg BID. After consultation with maternal-fetal
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medicine and endocrinology, surgical resection was recommended in the second
trimester due to maternal-fetal complications associated with adrenal adenomas in
pregnancy. In addition, current guidelines recommend resection for adenomas greater
than 4 cm due to concern for adrenocortical carcinoma.1 Preoperative workup included
magnetic resonance imaging without contrast, demonstrating an unchanged mass, and
repeat endocrine lab studies. Preoperative lab testing was helpful as aldosterone was
found to be within normal limits, thereby making primary aldosteronism less likely.
Additionally, the patient had a suppressed ACTH of <9 pg/mL (normal range: 9-46
pg/mL) at 15 weeks gestation and on repeat testing at 17 weeks. This result, paired with
the initial low DHEA finding, led to the diagnosis of subclinical Cushing syndrome.
Pregnancy induced alterations in diagnostic hormonal labs, such as dexamethasone
suppression test and urine free cortisol, made definitive diagnosis of subclinical Cushing
syndrome more difficult. However, the suppressed ACTH on repeat testing, which is
typically normal to high in pregnancy, strongly suggested a functional adrenocortical
adenoma.2 Based on the size of the mass, functionality and associated risk of
hypertension on the pregnancy, adrenalectomy was the best option, per maternal-fetal
medicine and endocrinology.

At 19 weeks gestation, the patient underwent an uncomplicated right robotic
adrenalectomy with the da VinciTM Si (Figure 2), with minimal adjustment in surgical
technique under general anesthesia. A Veress needle was used for abdominal access
and establishing pneumoperitoneum. Port placement was mildly cephalad to account for
the gravid uterus. An 8 mm planned camera port was placed in the midclavicular line
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and a 30-degree camera was inserted to survey the abdomen. There was no evidence
of adhesive disease. Under direct visualization, an 8 mm working port was placed just
under the costal margin at the midclavicular line. Two additional 8 mm robotic ports
were placed, a standard port caudal on the midclavicular line and finally a long port just
off the anterior superior iliac spine for the fourth arm. A 12 mm assistant port and 5 mm
liver retractor port were placed in the midline above the umbilicus. A maximum
pneumoperitoneum of 12mmHg was maintained throughout the procedure. She was
pre-treated with 2 mg dexamethasone for perioperative steroid coverage. The surgical
duration was 118 minutes with an estimated blood loss of 50 cc. A pre- and post-op
fetal ultrasound were done showing appropriate fetal heart rates. Post-operatively, she
received an additional 2 mg dexamethasone. A cosyntropin stimulation test to evaluate
the hypothalamic-pituitary axis was completed on the first postoperative day (POD) and
found to be low, consistent with functional cortisol producing adenoma and subclinical
Cushing syndrome. Patient was discharged home POD 1 on 5 mg prednisone daily for
8 weeks for replacement steroids. Pathology report showed adrenocortical neoplasm,
consistent with adrenocortical adenoma with negative surgical margins (Figure 3). Her
blood pressure normalized 4 weeks postoperatively and she was taken off all
antihypertensive medications.

Due to compliance issues, the patient stopped the steroids three weeks
postoperatively and denied any symptoms, such as orthostatic signs, dizziness, or
palpitations. At 36 weeks gestation, cortisol and ACTH were abnormal, prompting
endocrinology to suggest stress steroid coverage with 100 mg hydrocortisone IV during
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delivery. Pregnancy progressed with no complications with an estimated fetal weight
2211 grams (37%) at 33 weeks. At 39 weeks, the patient delivered a healthy 2800 g
female via cesarean section due to fetal intolerance and failure to progress in the
second stage of labor. On postpartum day 3, she developed preeclampsia with severe
range blood pressures up to 182/120. The patient denied any symptoms, including
headache, chest pain, shortness of breath, vision changes and epigastric pain. She
declined magnesium sulfate for seizure prophylaxis. The patient was given labetalol 20
mg IV and started on labetalol 200 mg BID which was up titrated to 300 mg BID.
Patient was discharged on labetalol 300 mg TID, amlodipine 10 mg daily, and 5 mg
prednisone daily for one month of steroid coverage.

Discussion: Presented by Huda B. Al-Kouatly, M.D.
As modern imaging continues to advance, adrenal incidentalomas are more
frequently diagnosed, posing challenges to providers regarding management.3 The
majority of these lesions (80%) are benign.3 Herein, we present a case of a large
adrenal incidentaloma identified in a patient found to be pregnant during surgical
evaluation.
The workup for adrenal incidentaloma entails identifying malignant potential or
functional status using clinical, laboratory, and radiographic testing. The differential
diagnosis includes adrenocortical carcinoma, pheochromocytoma, primary
aldosteronism, Cushing syndrome, and benign adenoma. In this case, none of these
pathologies could be initially excluded. After biochemical workup, the low DHEA and
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ACTH led endocrinology to diagnose subclinical Cushing syndrome. This pathology is
defined as hypercortisolemia without the apparent physical manifestations of typical
Cushing syndrome.4 It usually presents as unilateral adrenal incidentalomas, as seen in
our case. Current recommendations on treatment remain controversial, but lean
towards surgery.4 Interestingly, hypercortisolemia can cause amenorrhea and
oligomenorrhea leading to infertility, features evidently absent in our patient’s case.5
Literature reports that untreated Cushing syndrome in pregnancy can lead to
maternal hypertension, preeclampsia, impaired glucose control, and increased rates of
premature birth, intrauterine growth restriction, spontaneous abortion, and stillbirth.6 Our
patient experienced asymptomatic postpartum preeclampsia. In addition to her treated
subclinical Cushing syndrome, she had additional risk factors of chronic hypertension,
obesity, and African-American race.
Diagnosis of the functional status of adrenalomas is complicated by physiologic
hormonal changes of pregnancy. The hypothalamic-pituitary axis is altered, resulting in
increased cortisol, aldosterone, and renin levels.7 However, catecholamine levels are
unchanged, so diagnosis of pheochromocytoma remains analogous to non-pregnant
patients.6 In contrast, the workup for Cushing syndrome is adjusted. The
dexamethasone suppression test is a common initial workup for Cushing syndrome in
non-pregnant patients. However, its utility in pregnancy is limited as ~40% of pregnant
patients have abnormal dexamethasone suppression.6 This leads to increased Type I
Error, with literature endorsing false positive dexamethasone suppression tests in >80%
of normal pregnant women.6,8 To account for this, urine free cortisol may be used, as it
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is elevated at most to three times the upper limit of normal in pregnancy after the first
trimester.8 Therefore, it can be helpful if levels are >3 times the upper limit of normal.
Robotic adrenalectomy is considered equivalent to laparoscopic adrenalectomy,
which is arguably the standard of care. Initially it was believed that laparoscopy was
contraindicated in pregnancy, as the implications of the pneumoperitoneum on the
mother and developing fetus were of concern.9,10 Specifically, the carbon dioxide
exposure to the fetus and the increased intraabdominal pressure on the mother’s
already altered physiology were thought to pose more risk than benefits. However, it
has since been shown that the laparoscopic approach did not have additional risk and
was superior to the open approach in terms of length of stay, diet advancement and
duration of narcotic use.11 The first successful laparoscopic adrenalectomy in pregnancy
was reported in 1999 and quickly became the preferred method of intervention. 12 The
use of the robot builds on the advantages of laparoscopy in pregnant patients by
allowing for three-dimensional visualization, precise dissection and resection, and finetuned articulations. The ergonomics of the technology, in the hands of a skilled robotic
surgeon, make this ideal for manipulation around the gravid uterus. A recent metaanalysis in non-pregnant patients compared robotic adrenalectomy to laparoscopic and
demonstrated lower blood loss, shorter hospital stays, and no difference in conversion
rates.13 Furthermore, Brunaud et al. demonstrated that, when controlling for learning
curve of robotic usage, there was no significant difference in operation duration between
the two approaches.14 In regard to the timing of surgery, second trimester intervention
reduces risk of spontaneous abortion. Organogenesis is mostly complete by this time
and the uterine size does not limit surgical access, making this the ideal period for
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intervention.6 Potential disadvantages of the robotic approach include upfront costs of a
robotic system, although with each subsequent use the cost of an individual procedure
decreases. Additionally, set up and footprint in the operating room can limit its practical
use.
A literature review showed two robotic adrenal surgeries in pregnancy in addition
to this case.5,15 Podolsky et al. employed similar pregnancy-related robotic modifications
while performing their right adrenalectomy indicated for pheochromocytoma. These
included second trimester timing of surgery and maximum pneumoperitoneum of 12
mmHg. This latter modification limits deleterious effects on the fetus and mother, while
still providing adequate visualization. Their case had an operative duration of 270
minutes, estimated blood loss of 350 cc and the patient was discharged on POD 4. Key
to proper management in Podolsky’s case, as well as ours, was the prompt
determination of the functional status of the tumor along with perioperative care
appropriate to the specific nature of the functional mass. Additionally, they suggest
continuous monitoring for acidosis and placing the patient in left lateral cubitus
positioning to maximize maternal cardiac output and uterus and placental blood flow.15
Nassi et al. also described a cortisol producing mass in their report, but their patient
demonstrated physical symptoms of Cushing with moon facies, acne, hirsutism, and
proximal muscle weakness. They also elaborated on the challenges of Cushing
diagnosis in pregnancy, and ultimately decided to intervene in the second trimester due
to fetal risks of adrenal pathology. Critical to the patient safety was the additional
endocrine medical management of the patient with steroid replacement therapy
intraoperatively, post-operatively and post-partum. Similar to our patient, Nassi et al.
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described a healthy neonate that did not need glucocorticoid replacement during the
neonatal period.5 These reported cases demonstrate the utility of robotic adrenalectomy
in pregnancy, especially due to the maternal-fetal complications associated with
untreated adrenal disease.
Despite description of partial adrenalectomy in the literature,16,17 given that the
patient was pregnant, it seemed prudent to perform a more definitive procedure to
prevent extended operative time or reentry. Additionally, the adenoma’s anatomy,
which was central with involvement of a medial limb, made total adrenalectomy a more
attractive approach. However, since the procedure was successful, there is no clear
contraindication to a partial adrenalectomy in this situation for future cases and
amenable lesions.

Conclusion:
This case demonstrates the complexity of diagnosing adrenal adenomas in
pregnancy, as physiologic hormonal changes can interfere with standard diagnostic
testing. Robotic adrenalectomy should be considered as a feasible surgical treatment
alternative in second trimester pregnant patients in the hands of a competent robotic
surgeon. A multidisciplinary team approach is pivotal for delivery of best patient care.

9

Table 1 – Biochemical evaluation from initial hospital admission prior to pregnancy and
preoperative testing during the second trimester. Values are plasma unless specified
otherwise.
Pre-pregnancy hospital admission testinga
First Hospital Admission
Normal Range
(non-pregnant)
Aldosterone, ng/dL
3
<28
PRA, ng/mL/h
0.08
0.9-28.9
Aldosterone:PRA ratio
37.5
0.9-28.9
Metanephrine, pg/ml
<35
<57
Normetanephrine, pg/mL
<57
<148
24 hr urine
metanephrine,
44
36-190
catecholamine,
155
35-482
mcg/24 hr
Testosterone, ng/dL
17
2-45
Androstenedione, ng/dL
108
follicular phase: 35-250;
luteal phase: 30-235
DHEA, mcg/dL
43
45-430
Potassium, mmol/L
2.9
3.3-4.8
Preoperative 2nd trimester testing
Preoperative
Normal
Normal
Normal
Testing
Range
Range
Range
(1st Trimester) (2nd Trimester) (3rd Trimester)
Aldosterone, ng/dL
13
6-104
9-104
15-101
PRA, ng/mL/h
ACTH, pg/mL

1.42
<9
<9b
3.4

7.5-54.0
6 - 50

5.9-58.8
6 - 50

Potassium, mmol/L
3.6-5.0
3.3-5.0
PRA, plasma renin activity
a Pregnancy test done prior to CT scan was negative
b Repeat ACTH done at 2-week interval after initial measurement
c ACTH values unchanged in pregnancy2

3.3-5.1

6 – 50c

10

Figure 1 - CT scan identifying 4.2 cm right adrenal incidentaloma with heterogeneously
attenuating lesions and punctate calcifications
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Figure 2 - A. Gravid uterus identified during port placement B. Adrenal Mass identified
with isolation of the adrenal vein C. Adrenal fossa after resection showing clipped
adrenal vein (arrow), upper pole of kidney, liver, inferior vena cava and duodenum.
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Figure 3 - A. Tumor surrounded by thin capsule, with a rim of residual normal adrenal
tissue, 40x magnification. B. Tumor cells, 100x magnification. C. Focus of infarct
necrosis, 40x magnification.
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